Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Pathogens (Basel, Switzerland)|January 21, 2023
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine DevelopmentChristin Schmidt, Barbara S SchnierleChemistry (Weinheim an Der Bergstrasse, Germany)|November 11, 2021
Total Synthesis and Structural Assignment of (-)-Fusaequisin AAnn-Christin Schmidt, Martin HiersemannDrug Design, Development and Therapy|October 24, 2022
Chikungunya Vaccine Candidates: Current Landscape and Future ProspectsChristin Schmidt, Barbara S SchnierleViruses|July 2, 2021
Development of a Sensitive Detection Method for Alphaviruses and Its Use as a Virus Neutralization AssayChristin Schmidt, Mario Perkovic, Barbara S SchnierleIucrdata|November 7, 2022
(2<i>R</i>,4<i>S</i>,5<i>S</i>)-5-Meth-oxy-4-methyl-3-oxohept-6-en-2-yl benzoateAnn-Christin Schmidt, Lyuba Iovkova, Martin HiersemannViruses|July 27, 2024
The Stop Codon after the nsp3 Gene of Ross River Virus (RRV) Is Not Essential for Virus Replication in Three Cell Lines Tested, but RRV Replication Is Attenuated in HEK 293T CellsChristin Schmidt, Julia Gerbeth, Christine von Rhein, et al.Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|March 5, 2019
[Adult ADHD and borderline personality disorder: A pilot study on differences in attachment and early traumatization]Anne-Christin Schmidt, Thorsten-Christian Gablonski, Wolfgang Wladika, et al.Molecular Therapy. Nucleic Acids|June 6, 2022
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infectionsChristin Schmidt, Erik Haefner, Julia Gerbeth, et al.Vaccines|September 23, 2022
A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune ResponsesChristin Schmidt, Florian D Hastert, Julia Gerbeth, et al.The Journal of General Virology|April 8, 2021
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infectionLisa Henss, Arne Auste, Christoph Schürmann, et al.Pageof 3